ENHANCEMENT OF TAG-72 ANTIGEN EXPRESSION IN HORMONE-ASSOCIATED OVARIAN BORDERLINE SEROUS TUMORS

被引：0
|
作者：
CAJIGAS, HE [1 ]
FARIZA, E [1 ]
SCULLY, RE [1 ]
THOR, AD [1 ]
机构：
[1] MASSACHUSETTS GEN HOSP, DEPT PATHOL, BOSTON, MA 02114 USA
来源：
LABORATORY INVESTIGATION | 1990年 / 62卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A14 / A14
页数：1
相关论文
共 50 条
  • [31] REACTIVITY OF THE MONOCLONAL-ANTIBODY B72.3 WITH FETAL ANTIGEN - CORRELATION WITH EXPRESSION OF TAG-72 IN HUMAN CARCINOMAS
    STANICK, D
    SCHUSS, A
    MISHRIKI, Y
    CHAO, S
    THOR, A
    LUNDY, J
    CANCER INVESTIGATION, 1988, 6 (03) : 279 - 287
  • [32] Differential Nuclear Expression of Aurora A Kinase in Benign, Borderline, and Malignant Serous Ovarian Tumors
    Crane, J. E.
    Schultz, D. S.
    Inamdar, K. V.
    Lehman, N. L.
    LABORATORY INVESTIGATION, 2010, 90 : 238A - 238A
  • [33] Fallopian tube calcifications and chronic salpingitis associated with ovarian serous borderline tumors (SBT)
    Seidman, JD
    Sherman, ME
    Kurman, RJ
    MODERN PATHOLOGY, 1998, 11 (01) : 114A - 114A
  • [34] TUMOR-ASSOCIATED GLYCOPROTEIN (TAG-72) IN OVARIAN CARCINOMAS DEFINED BY MONOCLONAL-ANTIBODY B72.3
    THOR, A
    GORSTEIN, F
    OHUCHI, N
    SZPAK, CA
    JOHNSTON, WW
    SCHLOM, J
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1986, 76 (06) : 995 - 1006
  • [35] Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas
    Bell, KA
    Sehdev, AES
    Kurman, RJ
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (04) : 419 - 432
  • [36] Characterization of a new breast cancer-associated antigen and its relationship to MUC1 and TAG-72 antigens
    Harada, Y
    Ohuchi, N
    Masuko, T
    Funaki, Y
    Mori, S
    Satomi, S
    Hashimoto, Y
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 180 (03): : 273 - 288
  • [37] IMMUNOHISTOCHEMICAL EXPRESSION OF TAG-72 IN NORMAL AND MALIGNANT ENDOMETRIUM - CORRELATION OF ANTIGEN EXPRESSION WITH ESTROGEN-RECEPTOR AND PROGESTERONE-RECEPTOR LEVELS
    SOISSON, AP
    BERCHUCK, A
    LESSEY, BA
    SOPER, JT
    CLARKEPEARSON, DL
    MCCARTY, KS
    BAST, RC
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (05) : 1258 - 1263
  • [38] CHARACTERIZATION OF THE SHED FORM OF THE HUMAN TUMOR-ASSOCIATED GLYCOPROTEIN (TAG-72) FROM SEROUS EFFUSIONS OF PATIENTS WITH DIFFERENT TYPES OF CARCINOMAS
    KATARI, RS
    FERNSTEN, PD
    SCHLOM, J
    CANCER RESEARCH, 1990, 50 (16) : 4885 - 4890
  • [39] 1Does micropapillarity in ovarian serous borderline tumors represent a transition between typical ovarian serous borderline tumors and low grade serous carcinoma? Finding answers using the level of selenium-binding protein expression in 64 ovarian tumors
    Zhang, C
    Wang, YE
    Zhang, P
    Liu, F
    Sung, CJ
    Quddus, MR
    Steinhoff, MM
    Lawrence, WD
    LABORATORY INVESTIGATION, 2006, 86 : 203A - 203A
  • [40] Immunohistochemical study of the expression CD44 in serous, borderline, malign surface epithelial ovarian tumors and metastatic ovarian tumors
    Yurdakan, Gamze
    Kandemir, Nilufer Onak
    Colak, Sacide
    Gul, Aylin Ege
    Karadayi, Nimet
    Ozdamar, Sukru Oguz
    VIRCHOWS ARCHIV, 2007, 451 (02) : 403 - 403
12345